President: Worldwide Initiative for Diabetes Education
Chair: EURADIA: Alliance for European Diabetes Research
Visiting Professor: University of Miami, FL.
Consultant Physician: Manchester Royal Infirmary
Past-President: European Association for the Study of Diabetes
Prof. Brian Frier
Professor Brian M Frier, BSc (Hons), MD, FRCP(Edin), FRCP(Glas)
Professor Frier is Honorary Professor of Diabetes in the Queen’s Medical Research Institute at the University of Edinburgh. He was previously Consultant Physician in general medicine and diabetes at the Royal Infirmary of Edinburgh from 1987-2012 and at the Western Infirmary and Gartnavel General Hospital, Glasgow, from 1982-1987. Hypoglycaemia, with relevance to diabetes, has been his principal research interest for 40 years, and he has published extensively in this field. He served as the Chairman of the UK National Advisory Panel on Driving and Diabetes from 2001-2012 and was Vice-President of the Royal College of Physicians of Edinburgh from 2008-2012.
Prof. Philip Home
Philip Home is Professor of Diabetes Medicine at Newcastle University He was Vice-chair of the NICE Appraisal Committee, the UK drug reimbursement advisory committee and Consultant Physician in Newcastle (both to 2011), and has been Clinical Lead to UK and International Diabetes Federation guidelines. He was previously President of IDF Europe and Vice-President of the IDF. He was the Programme Committee Chair for IDF World Diabetes Congress, Montreal, 2009. His major research interest is new therapies for diabetes management, insulin, other injectables and oral agents – over 430 full length publications.
Prof. Leszek Czupryniak
Prof Leszek Czupryniak is a physician researcher, involved mostly in clinical studies on pathogenesis and treatment of type 2 diabetes mellitus, hypertension, and obesity, with particular interest in mechanisms responsible for their co-existence. He has been also investigating cardiovascular risk factors in diabetes and obese subjects, including endothelial dysfunction studies in vivo and obstructive sleep apnoea syndrome. Since 2015 he has been working as a head of the Department of Diabetology and Internal Medicine at the Warsaw Medical University, in Warsaw, Poland.
He graduated from Medical University of Lodz, Poland, in 1994, is a specialist in internal medicine and diabetology, completed his doctorate thesis on homocysteine metabolism in type 2 diabetes in 2001, and habilitation thesis on blood pressure regulation in type 2 diabetes and obesity in 2008. His medical and research training included scholarship or courses at the United Kingdom Prospective Diabetes Study centre (Oxford Centre for Diabetes, Endocrinology and Metabolism) in Oxford (UK), Maastricht (the Netherlands), King’s College, London (UK), Wakefield (UK), Miami (USA).
He served as the president of Diabetes Poland (professional scientific Polish diabetes association, 2011-2015), is a a member of the Executive Committee of the European Association for the Study of Diabetes (EASD), since 2013 serving the post of Chair of the EASD Postgraduate Education Committee. The latter activity led him to lecture and run workshops at the EASD Postgraduate Courses across Europe as well as in China, Vietnam, India, Sri Lanka, Pakistan, Georgia, Armenia, Mongolia, Azarbaijan, Kazakhstan, Uzbekistan, Iran, Oman, UAE, Kuwait, Bahrain, Qatar, Ethiopia, South Africa since 2009. In 2000-08 he was an active member of the EASD Hypertension in Diabetes Study Group, in 2007 was elected to the Executive Committee of the Group. Since 2004 he has been organizing biannually EASD Minkowski Postgraduate Course in Clinical Diabetes in Wroclaw (Breslau) in Poland.
He is an author or co-author of over 150 original papers published in international journals including Diabetes Care, Diabetic Medicine, Journal of Clinical Endocrinology and Diabetes, Experimental and Clinical Endocrinology and Diabetes, American Journal of Hypertension, Journal of Human Hypertension, Obesity Surgery, Diabetes Technology and Therapeutics, Sleep Medicine, with total Impact Factor over 150. His letters were published in New England Journal of Medicine, Diabetologia, American Journal of Medicine and The Lancet. He also authored or co-authored 8 monographies on diabetes, 110 reviews and 35 book chapters. He is also a member of the Editorial Consultant Board at The Lancet, associete editor at the Diabetic Medicine, member of the Editorial Board of the Diabetes, Obesity and Metabolism; Cardiovascular Endocrinology and Endocrine Oncology and Metabolism as well as a regular reviewer at the American Journal of Hypertension, British Journal of General Practice, Diabetic Medicine, Journal of Diabetes and Its Complications, and Experimental and Clinical Endocrinology and Diabetes.
For 14 years he was a managing editor of the Polish Journal of Diabetology, the first diabetes scientific journal in Poland. He is a member of several national and international professional medical associations, including ADA. More privately, he is an avid collector of diabetes memorabilia, and inspired by Michael Bliss’ book “Discovery of Insulin” in 2003 and 2004 he conducted research and published the account of the history of the beginnings of insulin production in Poland in 1924.
Dr. Beverley Balkau
Beverley Balkau is an Emeritus Director of Research in INSERM - U1018, CESP (Centre for Research in Epidemiology and Population Health), team “EpReC Renal and cardiovascular Epidemiology”, Villejuif, France.
Her research interests include the epidemiology of the insulin resistance syndrome, diabetes epidemiology and screening and diagnostic criteria for diabetes. DrBalkau is the author of more 500 peer reviewed articles. She is the Principal Investigator of the D.E.S.I.R. Study (Data on an Epidemiological Study of the Insulin Resistance syndrome), a 9-year longitudinal study of 5200 people recruited in 1994, and is an investigator and member of the project management board of the EGIR-RISC (European Group for the study of Insulin Resistance - Relationship between Insulin Sensitivity and Cardiovascular risk) a prospective study of 1300 people with insulin resistance measured by the hyperinsulinaemiceuglycaemic clamp at baseline and followed for cardiovascular events and progression of the atherosclerosis. DrBalkau was also one of the principal investigators in the DECODE study, a meta-analysis of existing European epidemiological studies to investigate the diagnostic criteria for diabetes. She currently collaborates with the E3N cohort study, the French contribution to the EPIC and InterAct studies, for research work on diabetes. She spends time in Australia each where she works with the diabetes group at the Baker IDI heart and diabetes institute in MelbourneC.
Her research in this field and her activities teaching international seminars on the epidemiology of diabetes led to her being chosen for the Peter Bennett Award from the International Diabetes Epidemiology Group in 2006 and to the Kelly West Award from the American Diabetes Association in 2007.
Asst. Prof. Dario Rahelic
MD, PhD, FACE, FRCP Edin
President of Croatian Society for Diabetes and Metabolic Diseases
Head of Department of Endocrinology, Diabetes and Clinical Pharmacology
Dubrava University Hospital
Prof. Dr. Elisabete Weiderpass
Trained in medicine (1992) and epidemiology (M.Sc., 1994) in Brazil, and in cancer epidemiology at the KarolinskaInstitutet in Stockholm (Ph.D., 1999; post doc 1999-2000).
he serves as Head of the Department of Research at the Cancer Registry of Norway - Institute of Population Based Cancer Research. She is a Professor of Medical Epidemiology at the KarolinskaInstitutet, a Professor of Cancer Epidemiology at the Arctic University of Norway, and the Group Leader of the Genetic Epidemiology Group, Folkhälsan Research Center and Visiting Professor at Helsinki University, Helsinki, Finland.
She is an elected member of the WHO International Agency for Research on Cancer Scientific Council. Her main research interests are cancer etiological and prognostic factors, cancer prevention, cancer survival, and cancer registration. She has published extensively in these fields of research (over 630 peer reviewed publications in international journals).
Dr. Henri Tuomilehto
Medical Director, Oivauni Sleep Clinic, Helsinki, Kuopio and Tampere, Finland
Henri Tuomilehto is one of the rare full-time sleep physicians in world. He is leading three sleep clinics in Finland treating hundreds of patients with different sleep disorders each year. Besides clinical work he has also been involved with sleep research for the last 15 years. His study group was the first the demonstrate that healthy lifestyle aiming at weight reduction can improve, even cure obstructive sleep apnea (OSA).
Henri’s most important publications address the association between obesity, sleep disorders and type 2 diabetes. Furthermore, the main focus is on treating and, particularly preventing these chronic diseases with healthier diet and physical activity. In Finland Henri Tuomilehto has also been the one of most used expert in media related to sleep. Recently, he has been working with the top athletes of Finnish Olympic Committee in a search for improved recovery by better sleep.
Prof. Jaakko Tuomilehto
MD, MA (sociology), PhD, FRCP(Edin)
Is working as the Chief Scientific Officer at Dasman Diabetes Institute in Kuwait. He is Professor Emeritus of Public Health of the University of Helsinki, Finland. He is also affiliated with the Chronic Disease Prevention Unit of the Finnish National Institute for Health and Welfare, the Danube-University Krems in Austria, and Diabetes Research Group at King Abdulaziz University, Jeddah, Saudi Arabia.
His research interests include the epidemiology and prevention of non-communicable diseases such as diabetes, cardiovascular disease, cancer and dementia. He has contributed many landmark studies, including the Finnish Diabetes Prevention Study (DPS) that in 2001 demonstrated a remarkable 58% reduction in the incidence of diabetes with lifestyle intervention.
He was the Principal Investigator of the WHO DIAMOND Project mapping the incidence of childhood type 1 diabetes worldwide. He also established large international collaborative studies of diabetes epidemiology, the DECODE/DECODA (Diabetes Epidemiology-Collaborative analysis of Diagnostic Criteria in Europe/Asia) studies that have assessed the glucose criteria for the diagnosis of diabetes.
He has been acting as a member several American Diabetes Association (ADA) and WHO committees on the definition and diagnostic criteria of diabetes. He has played an active role within the European Society of Cardiology, and was the member of the recent “Diabetes and Cardiovascular Disease Guideline” task force.
He is actively involved in several other committees, scientific organisations, editorial boards and advisory boards nationally and internationally. Currently he serves as the Editor-in-Chief of Primary Care Diabetes. He has received many prestigious scientific awards, including the ADA Kelly West Award and Harold Rifkin Award, EASD Camillo Golgi Award and ESC Geoffrey Rose Award. He has contributed to over 1600 scientific peer-reviewed publications, and is one of the most cited authors in the field of clinical medicine and diabetes worldwide with h-index 153.
Dr. Mahmoud Ibrahim USA
Prof. Nam Cho
President of the International Diabetes Federation for 2018-19. He previously served as Chair of the IDF Western Pacific Region (IDF-WPR) for 2013-2015.
Dr. Cho became interested in diabetes in 1984 and has developed an academic career in diabetes research that focuses on clinical epidemiology. He is a world renowned diabetes epidemiologist.
He graduated from the University of Pittsburgh with a clinical epidemiology degree in 1989 and was a medical faculty member at Northwestern University Medical School in Chicago until he was recruited by the Korean government's “Korean national brain pool recruitment project” in 1994. He has published over 200 peer reviewed papers on type 1 diabetes, type 2 diabetes, and gestational diabetes.
Dr. Cho has served as chairman of the Department of Preventive Medicine at Ajou University School of Medicine and is a director of clinical epidemiology at the University's Hospital. He is also CEO and owner of two companies. Since 2000 he has served as the president of a humanitarian medical NGO which provides medical services to under-developed countries. In 2015 he received an insignia from the King of Cambodia for 15 years of unselfish humanitarian medical services and the construction of a National Diabetes Center.
Prof. Sean Dinneen
National Lead for the Diabetes Clinical Programme
Professor of Diabetic Medicine, National University of Ireland, Galway, Ireland
Professor of Diabetic Medicine, National University of Ireland, Galway, Ireland
Professor Seán Dinneen is Consultant Endocrinologist at Galway University Hospitals and holds a Personal Professorship in Diabetic Medicine. He served as Head of the School of Medicine in NUI Galway from 2013 to 2016. In June 2016 he was appointed National Lead for the Diabetes Clinical Programme of the HSE’s Clinical Strategy and Programmes Division.
Having graduated from University College Cork Medical School he trained and worked in the USA (Mayo Clinic), Canada (McMaster University) and the UK (Addenbrooke’s Hospital, Cambridge) before returning to Ireland in 2005. His professional interests include developing and evaluating programmes of self-management education and support for people living with diabetes, developing optimal models of community-based diabetes care and understanding the diabetic foot. He has secured research funding from the Health Research Board, Enterprise Ireland, Diabetes Ireland, the European Foundation for the Study of Diabetes and Galway University Foundation. He was part of successful bids which brought a School of Podiatry and a Clinical Research Facility to NUI Galway.
Professor Dinneen is actively involved in undergraduate and postgraduate education through the College of Medicine Nursing and Health Sciences at NUI Galway and serves as co-chair of the Postgraduate Education Committee of EASD, the European Association for the Study of Diabetes. He is Clinical Lead for Schwartz Rounds in Galway University Hospitals. Professor Dinneen currently serves as an Associate Editor of Diabetic Medicine, the journal of Diabetes UK.
Dr. Shaukat Sadikot
Dr. Shaukat M. Sadikot, President of the International Diabetes Federation (IDF)
Past Vice President, International Diabetes Federation.
President, DiabetesIndia .
Core group member of the Metabolic Syndrome Institute,
Vice President , International Atherosclerosis Society
Executive Board member of the Residual Risk Initiative (R3I),
Editor-In Chief: Diabetes and Metabolic Syndrome: Clinical Research and Reviews.
Author of 5 Books
Presently, Con. In Endocrinology, Diabetes and Metabolic Disorders at Jaslok Hospital and Research Centre, Mumbai, India
MCI Middle East
United Arab Emirates
Tel: +971 4 311 6300
Fax: +971 4 311 6301
Email : firstname.lastname@example.org